Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$382.0M
21M shares
52-week range
$10.92 – $24.60
50% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
P/S (TTM)
6.1
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
www.shoulderinnovations.comNo one on the platform currently holds SI.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 12,300 | $175.9K |
No one on the platform has traded SI yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $68M | +50.2% | $-1.88 | $-1.92–$-1.85 | — | 2 |
| 2027 | $88M | +29.2% | $-1.57 | $-1.60–$-1.55 | — | 2 |
| 2028 | $111M | +25.3% | $-1.43 | $-2.40–$-1.00 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $-0.46 | $-0.46 | -0.3% |
| 2026-05-13 | $-0.44 | $-0.41 | +6.8% |
| 2026-03-10 | $-0.42 | $-0.38 | +9.5% |
| 2025-11-11 | $-0.37 | $-0.48 | -29.7% |
| 2025-09-09 | $-0.01 | $-0.64 | -10131.7% |
| -0.12% |
| $270M |
| — |
| INGNInogen, Inc. | $5.23 | -0.02% | $142M | — |
| MDXHMDxHealth S.A. | $0.69 | -3.05% | $35M | — |
Source: Financial Modeling Prep · peers by sector/industry
$SI deployed an exclusive partnership with ALM Ortho to launch a bespoke shoulder implant for complex reconstructions.
View on StockTwits ↗🚨 RUNNER LONGS—2 contracts each: $GC.X 4,500.2 $SI 66.935 $ES 7,709.50 $NQ 29,466.25 ⏳ $YM LONG 2 pending at 53,533. One contract captures the move. One becomes the runner. 🏃
View on StockTwits ↗🚨 RUNNER STRATEGY — LONG ENTRIES Four markets have triggered long positions with two contracts each: 🟡 $GC.X Gold LONG 2 @ 4,500.2 ⚪ $SI Silver LONG 2 @ 66.935 🟣 $ES S&P 500 LONG 2 @ 7,709.50 🔵 $NQ Nasdaq LONG 2 @ 29,466.25 ⏳ PENDING TRIGGER: 🟠 $YM Dow LONG 2 if price reaches 53,533 One contract can capture the initial move while the second is given room to become the runner. Now we follow the process and let the markets tell the story. JAMES OLIVER TRADES
View on StockTwits ↗📊 RUNNER WEEKLY RECAP 88 trades—nearly twice the normal weekly volume. ✅ 31 winners 🛑 57 stops 📈 35.2% win rate 💪 4.90x profit factor 🏃 Average winner: 9.02x average stop $NQ +1,153.25 points $YM +881 points $ES +87.50 points $GC +74.50 points $CL +7.01 points $SI +1.655 points All six markets finished net positive—even after Friday’s violent reversal. The win rate isn’t the story. The size of the runners is. This strategy is looking more and more like a survivor.
View on StockTwits ↗Market Prep | Week commencing Aug 17 Light week for fundamentals. FOMC minutes and not much else. → Memory + $SMH leading with gap up opens → Relative weakness in software, inverse relationship intact → Watching if the MAGS bulls hold that daily bull flag → $GC.X and $SI both set a quick daily higher low off Friday's low, flags alive → Photonics, Neoclouds and the other sub-sectors bringing the volatility Daily and hourly uptrends stay the guide. Burden's on the bears to show us something's shifted. I'm staying bullish until the market says otherwise.
View on StockTwits ↗$DCTH did well $RCEL did well $APYX did fine $SI did spectacularly. $PROF did things we don't want to say lol
View on StockTwits ↗$SI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.49 up 99.70% YoY • Reported revenue of $17.18M up 55.95% YoY • Shoulder Innovations raised full year 2026 net revenue guidance to a range of $67 million to $69 million, representing growth of approximately 42% to 46% over full year 2025 net revenue.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.